Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management

Elaina Vivian, Leslie Cler, Darwin Conwell, Gregory A. Coté, Richard Dickerman, Martin Freeman, Timothy B. Gardner, Robert H. Hawes, Prashant Kedia, Rajesh Krishnamoorthi, Hellen Oduor, Stephen J. Pandol, Georgios I. Papachristou, Andrew Ross, Amrita Sethi, Shyam Varadarajulu, Santhi Swaroop Vege, Wahid Wassef, C. Mel Wilcox, David C. WhitcombBechien U. Wu, Dhiraj Yadav, Ashton Ellison, Samar Habash, Sheila Rastegari, Rathan Reddy, Timothy Yen, Mary Rachel Brooks, Paul Tarnasky

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

INTRODUCTION: Detailed recommendations and guidelines for acute pancreatitis (AP) management currently exist. However, quality indicators (QIs) are required to measure performance in health care. The goal of the Acute Pancreatitis Task Force on Quality was to formally develop QIs for the management of patients with known or suspected AP using a modified version of the RAND/UCLA Appropriateness Methodology. METHODS: A multidisciplinary expert panel composed of physicians (gastroenterologists, hospitalists, and surgeons) who are acknowledged leaders in their specialties and who represent geographic and practice setting diversity was convened. A literature review was conducted, and a list of proposed QIs was developed. In 3 rounds, panelists reviewed literature, modified QIs, and rated them on the basis of scientific evidence, bias, interpretability, validity, necessity, and proposed performance targets. RESULTS: Supporting literature and a list of 71 proposed QIs across 10 AP domains (Diagnosis, Etiology, Initial Assessment and Risk Stratification, etc.) were sent to the expert panel to review and independently rate in round 1 (95% of panelists participated). Based on a round 2 face-to-face discussion of QIs (75% participation), 41 QIs were classified as valid. During round 3 (90% participation), panelists rated the 41 valid QIs for necessity and proposed performance thresholds. The final classification determined that 40 QIs were both valid and necessary. DISCUSSION: Hospitals and providers managing patients with known or suspected AP should ensure that patients receive high-quality care and desired outcomes according to current evidence-based best practices. This physician-led initiative formally developed 40 QIs and performance threshold targets for AP management. Validated QIs provide a dependable quantitative framework for health systems to monitor the quality of care provided to patients with known or suspected AP.

Original languageEnglish (US)
Pages (from-to)1322-1342
Number of pages21
JournalAmerican Journal of Gastroenterology
Volume114
Issue number8
DOIs
StatePublished - Aug 1 2019

Bibliographical note

Funding Information:
Guarantor of the article: Paul Tarnasky, MD, FACG, Chair, American College of Gastroenterology and ACG Institute’s Acute Pancreatitis Task Force on Quality, accepts full responsibility for the conduct of the study. Specific author contributions: E.V., P.K., H.O., and P.T. planned and conducted the study, collected and interpreted data, and drafted the manuscript. L.C., D.C., G.A.C., R.D., M.F., T.B.G., R.H.H., R.K., S.J.P., G.I.P., A.R., A.S., S.V., S.S.V., W.W., C.M.W., D.C.W., B.U.W., D.Y., A.E., S.H., S.R., R.R., T.Y., and M.R.B. participated in the study and/or drafted the manuscript. All authors have approved the final draft submitted. Financial support: The ACG Institute for Clinical Research & Education provided funding for this study, but the work was conducted independently. No writing assistance was provided for this manuscript. Potential competing interests: D.C.W. serves as a consultant for AbbVie, Regeneron, and Ariel Precision Medicine; received research support from Regeneron and Shire; cofounded and may have equity in Ariel Precision Medicine; is a board member of the National Pancreas Foundation and Ariel Precision Medicine; and is Editor-in-Chief, Clinical and Translational Gastroenterology and Pancreas Section Editor, UpToDate. All other authors disclosed no financial relationships relevant to this publication. This work was presented in abstract form (oral presentation) at the 2018 Annual ACG Meeting in Philadelphia, PA.

Publisher Copyright:
© 2019 by The American College of Gastroenterology.

Fingerprint

Dive into the research topics of 'Acute Pancreatitis Task Force on Quality: Development of Quality Indicators for Acute Pancreatitis Management'. Together they form a unique fingerprint.

Cite this